When George Perry began studying Alzheimer's disease less than 30 years ago, few scientists knew of the condition, let alone the public, which now cannot have a day pass without new revelations in the press.
What is this disease that so closely touches all our lives and seems so intractable to treatment? Is the heightened awareness due to our increased longevity, or its incidence?
While most therapeutics are directed to the effects of the disease, the future lies in modifying responses to aging to maintain normal function throughout our lifespan.
Dr. Perry is Dean and Professor of Biology, University of Texas-San Antonio, joining the UTSA faculty in 2006 from Case Western Reserve University where he was Professor of Pathology and Neurosciences and Chair of the Department of Pathology. He is also distinguished as one of the top 20 Alzheimer's disease researchers with over 800 publications; one of the top 100 most-cited scientists in neuroscience and behavior research; and one of the top 25 scientists in free radical research. He is Past President for the American Association of Neuropathologists, on the editorial board of over 60 journals, and is Editor-in-Chief of Journal of Alzheimer's Disease.
What is this disease that so closely touches all our lives and seems so intractable to treatment? Is the heightened awareness due to our increased longevity, or its incidence?
While most therapeutics are directed to the effects of the disease, the future lies in modifying responses to aging to maintain normal function throughout our lifespan.
Dr. Perry is Dean and Professor of Biology, University of Texas-San Antonio, joining the UTSA faculty in 2006 from Case Western Reserve University where he was Professor of Pathology and Neurosciences and Chair of the Department of Pathology. He is also distinguished as one of the top 20 Alzheimer's disease researchers with over 800 publications; one of the top 100 most-cited scientists in neuroscience and behavior research; and one of the top 25 scientists in free radical research. He is Past President for the American Association of Neuropathologists, on the editorial board of over 60 journals, and is Editor-in-Chief of Journal of Alzheimer's Disease.
Charla
Post a Comment